Arthritis Food Resources.
Other Arthritis Food & Arthritis Related Articles
Arthritis And Diet
Arthritis And Diet Arthritis can be helped by paying attention to your diet. Today lets take a look at minerals and the role they play in bone, ligament and cartilage health.MINERALS NEEDED IN THE DIET:Boron – This trace mineral aids in bone health.C
By: Jeannie Crabtree C.Ac..
Arthritis & Joint Health
Arthritis & Joint Health :Many millions of people are affected by pain and suffering from Arthritis and research has shown that Glucosamine and Chondroitin sulphates combined have given these people new hope and relief from their painful ailments. Ar
By: StarHerb.
Acupuncture and Arthritis
We have talked about acupuncture before. However, it has been some time ago and I wanted to bring this up and add some interesting points.Arthritis PainIt is no secret that I favor the use of a high-quality liquid Glucosamine to deal with the pain of
By: JR Rogers.
Updated Arthritis Related News - Arthritis Resources
Pozen stock roars on partnership worth up to $375M (bizjournals.com via Yahoo...
Pozen Inc. announced Wednesday a research and licensing deal with pharmaceutical giant AstraZeneca worth as much as $375 million to develop an arthritis pain reliever, sending Chapel Hill drug maker's shares soaring for the second time this week.
Shares of Pozen up nearly 40 percent after deal with AstraZeneca (The Herald-...
Shares of Pozen Inc. jumped nearly 40 percent Wednesday after the drug developer announced it will collaborate with a British firm on a drug designed to treat arthritis pain.
Pozen, AstraZeneca to Develop Pain Drug (AP via Yahoo! Finance)
Drug developer Pozen Inc. said Wednesday it will collaborate with British drug maker AstraZeneca PLC on the development of a combination pill that treats arthritis pain while lowering the risk of certain side effects common to some painkillers.
Pozen lands AstraZeneca deal worth up to $375M (Triangle Business Journal)
Pozen Inc. has struck a research and licensing deal with pharmaceutical giant AstraZeneca worth as much as $375 million to develop an arthritis pain reliever, sending Chapel Hill drug maker's shares soaring for the second time this week.
